Supplementary Files
How to Cite
Abstract
Objective: To compare the use of oral steroids and clarithromycin in the reduction of Nasal polyp score in pre-operative patients of FESS.
Methods: After the ethical approval from the institutional review board, this comparative study was conducted at the Department of Otorhinolaryngology, Head and Neck Surgery, Rawalpindi Teaching Hospital, Rawalpindi Medical University, Rawalpindi from December 2023 to May 2024. Through non-probability consecutive sampling, 60 patients aged between 18-60 years, with Bilateral Nasal polyps and clinically Grade 4, were included in the study.
Results: In terms of endoscopic scores, before treatment (Table 2), Group A had a mean score of 3.1 ± 0.6, while Group B had a higher baseline score of 3.6 ± 0.7, with a statistically significant difference between the two groups (p = 0.009). After treatment, the mean endoscopic score in Group A decreased to 2.3 ± 0.70, while in Group B, it decreased more substantially to 1.5 ± 0.56. This difference in post-treatment scores was highly significant (p < 0.0001) (Figure 1). The mean reduction in the endoscopic score was 0.8 ± 0.40 in Group A and 2.03 ± 0.9 in Group B, indicating a significantly greater decrease in Group B (p < 0.0001)
Conclusion: Clarithromycin has more anti-polyp effect in terms of size reduction than oral steroids, which provides a strong recommendation towards the management of FESS patients through pre-operative use of the drug.
References
Rasouli AA, Dyamely Z. Prevalence of nasal polyps in chronic rhinosinusitis patients undergoing functional endoscopic sinus surgery. Interdisciplinary Approaches to Medicine. 2021; 2(1):67-71.
Merrill T, Kanaan A. Managing chronic rhinosinusitis with nasal polyps in the elderly: challenges and solutions. Clin Interv Ageing. 2023; 18:685-98. https://doi.org/10.2147/CIA.S279765
De Corso E, Bilò MB, Matucci A, Seccia V, Braido F, Gelardi M, et al. Personalized management of patients with chronic rhinosinusitis with nasal polyps in clinical practice: a multidisciplinary consensus statement. J Pers Med. 2022; 12(5):846 https://doi.org/10.3390/jpm12050846
Poetker DM. Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: risks and benefits. Am J Rhinol Allergy. 2015; 29(5):339-42. https://doi.org/10.2500/ajra.2015.29.4223
De Corso E, Pipolo C, Cantone E, Ottaviano G, Gallo S, Canevari FRM, et al. Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs. J Pers Med. 2022; 12(6):897. https://doi.org/10.3390/jpm12060897
Ecevit MC, Erdag TK, Dogan E, Sutay S. Effect of steroids for nasal polyposis surgery: a placebo-controlled, randomized, double-blind study. Laryngoscope. 2015; 125(9):2041-5. https://doi.org/10.1002/lary.25352
Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The Immunomodulatory effects of macrolides—a systematic review of the underlying mechanisms. Front Immunol. 2018; 9:302. https://doi.org/10.3389/fimmu.2018.00302
Perić A, Baletić N, Milojević M, Sotirović J, Živić L, Perić A, et al. Effects of preoperative clarithromycin administration in patients with nasal polyposis. West Indian Med J. 2014; 63(7):721.
Chellappan DK, Prasher P, Shukla SD, Yee TW, Kah TK, Xyan TW, et al. Exploring the role of antibiotics and steroids in managing respiratory diseases. J Biochem Mol Toxicol. 2022; 36(10):e23174. https://doi.org/10.1002/jbt.23174
Bezerra TFP, Pezato R, Barros PMd, Coutinho LL, Costa LF, Pinna F, et al. Prospective evaluation of clarithromycin in recurrent chronic rhinosinusitis with nasal polyps. Braz J Otorhinolaryngol. 2021; 87(3):298-304. https://doi.org/10.1016/j.bjorl.2019.09.008
Lin C-F, Wang M-C, Merton AT, Ho N-H, Wu P-S, Hsu A, et al. Add-on effect of clarithromycin to oral steroids as post-operative therapy for chronic rhinosinusitis with nasal polyps: a randomised controlled trial. Rhinology. 2020; 58(6):550-8.
Tetik F, Korkut AY, Kaya KS, Ucak I, Celebi I, Coskun BU. Comparison of the oral steroids, macrolides and combination therapy in nasal polyposis patients. Med Bull Sisli Etfal Hosp. 2020; 54(2):211.
Shen S, Lou H, Wang C, Zhang L. Macrolide antibiotics in the treatment of chronic rhinosinusitis: evidence from a meta-analysis. J Thorac Dis. 2018; 10(10):5913. https://doi.org/10.1016/j.jaci.2017.09.009
Zhang Y, Gevaert E, Lou H, Wang X, Zhang L, Bachert C, et al. Chronic rhinosinusitis in Asia. J Allergy Clin Immunol. 2017; 140(5):1230-9. https://doi.org/10.1016/j.jaci.2017.04.023
Ranford D, Hopkins C. Safety review of current systemic treatments for severe chronic rhinosinusitis with nasal polyps and future directions. Expert Opin Drug Saf. 2021; 20(10):1177-89. https://doi.org/10.1080/14740338.2021.1926981
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. 2020.
Cain RB, Lal D. Update on the management of chronic rhinosinusitis. Infect Drug Resist. 2013; 6:1-14. https://doi.org/10.2147/IDR.S26134
Amali A, Saedi B, Rahavi-Ezabadi S, Ghazavi H, Hassanpoor N. Long-term postoperative azithromycin in patients with chronic rhinosinusitis: a randomised clinical trial. Am J Rhinol Allergy. 2015; 29(6):421-4. https://doi.org/10.2500/ajra.2015.29.4244
Philpott C, Le Conte S, Beard D, Cook J, Sones W, Morris S, et al. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial. Trials. 2019; 20:1-18. https://doi.org/10.1186/s13063-019-3314-7
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2025 Amna Javaid, Sadia Chaudhry, Sundas Masood, Adia Bushra, Saba Sahar, Ansa Umara